Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 200,926 shares at $52.06 ($10.5M) on 2022-06-24, disclosed to the SEC on 2022-06-28.
Open-market sale of $10.5M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.06 | 11,528 | $600K | 5.7% |
| 2 | $52.06 | 11,528 | $600K | 5.7% |
| 3 | $52.37 | 86,209 | $4.5M | 42.9% |
| 4 | $52.37 | 86,209 | $4.5M | 42.9% |
| 5 | $52.10 | 2,726 | $142K | 1.4% |
| 6 | $52.10 | 2,726 |
| $142K |
| 1.4% |
| Total | $52.33 avg | 200,926 | $10.5M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |